Smoking and schizophrenia;Tabaco y esquizofrenia

Adicciones

Volumn 16, Issue SUPPL. 2, 2004, Pages 177-190

  Martínez Ortega, José María ^a   Gurpegui, Manuel ^a,d   Díaz, Francisco J ^b   De Leon, José ^c  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^c Eastern State Hospital   (United States)

^d UNIVERSITY OF GRANADA   (Spain)

Author keywords

Nicotine; Schizophrenia; Smoking; Tobacco

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; NICOTINE; OLANZAPINE; POLYCYCLIC AROMATIC HYDROCARBON; TOBACCO SMOKE;

ANXIETY; COGNITION; DEPRESSION; DISEASE ASSOCIATION; DOPAMINE RELEASE; HUMAN; MENTAL DISEASE; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SELF MEDICATION; SMOKING; SMOKING CESSATION; SOCIAL CLASS; SOCIAL INTERACTION; TOBACCO DEPENDENCE;

EID: 3242689906     PISSN: 02144840     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Hughes JF, Hatsukamy DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 1986; 143: 993-7.
2. de Leon J, Dadvand M, Canuso C, White A.O, Stanilla J, Simpson GM. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry 1995; 152: 453-5.
3. de Leon J, Diaz FJ. Smoking in bipolar and schizophrenic patients [letter]. J Clin Psychiatry 2002; 63: 368-9.
4. Diwan A, Castine M, Pomerlau C, Meador-Woodruff JH, Dalack GW. Different prevalence of cigarette smoking in patients with schizophrenia vs. mood disorders. Schizophr Res 1998; 33: 113-8.
5. Llerena A, de la Rubia A, Peñas-Lledó EM, Diaz FJ, de Leon J. Schizophrenia and tobacco smoking in a Spanish psychiatric hospital. Schizophr Res 2003; 60: 313-7.
6. de Leon J, Tracy J, McCann E, McGrory A, Diaz FJ. Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital. Schizophr Res 2002; 56: 55-65.
7. Poirier MF, Canceil O, Baylé F, Millet B, Bourdel MC, Moatti C, et al. Prevalence of smoking in psychiatric patients. Progr Neuropsychopharmacol Biol Psychiatry 2002; 26: 529-37.
8. Tanskanen A, Viinamaki H, Koivuma-Honkanen HT, Jaaskelainen J, Lehtonen J. Smoking among psychiatric patients. Eur J Psychiatry 1998, 12: 109-18.
9. Arias-Horcajadas F, Padín-Calo JJ, Fernández- González MA. Consumo y dependencia de drogas en la esquizophrenia. Actas Luso-Esp Neurol Psiquiatr 1997; 25: 379-89.
10. Carvajal C, Passig C, San Martin RE, Zuñiga SA. Prevalencia del consumo de cigarrillos en pacientes psiquiátricos. Acta Psiquiatr Psicol Am Lat 1989; 35: 145-151.
11. Dalack GW, Healy D, Meador-Woodruff, JH. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry 1998; 155: 1490-501.
12. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 1997; 94: 587-92.
13. Shiffman S. Tobacco "chippers" - individual differences in tobacco dependence. Psychopharmacology 1989; 97: 539-47.
14. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addiction 1991; 86: 1119-27.
15. Fagerström KO, Kunze M, Schoberberger R, Breslau N, Hughes JR, Hurt RD, et al. Nicotine dependence versus smoking prevalence: Comparison among countries and categories of smokers. Tob Control 1996; 5: 52-6.
16. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes per day. Br J Addiction 1998; 84: 791-800.
17. de Leon J, Diaz FJ, Becoña E, Gurpegui M, Jurado D, Gonzalez-Pinto A. Exploring brief measures of nicotine dependence for epidemiological surveys. Addict Behav 2003; 28: 1481-86.
18. Calabresi M, Casu G, Dalle Luche R. La prevalenza del fumo di tabacco nei pazienti psichiatrici. Minerva Psichiatr 1991; 32: 89-92.
19. McCreadie RG, on behalf of Scottish Comorbidity Study Group. Use of drugs, alcohol, and tobacco by people with schizophrenia: case-control study. Br J Psychiatry 2002; 181: 321-25.
20. Srinivasan TN, Thara R. Smoking in schizophrenia - all is not biological. Schizophr Res 2002; 56: 67-74.
21. de Leon J, Diaz FJ, Rogers T, Browne D, Dinsmore L. Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders. Schizophr Res 2002; 56: 47-54.
22. Herrán A, de Santiago A, Sandoya M, Fernández MJ, Díez-Manrique JF, Vázquez-Barquero JL. Determinants of smoking behavior in outpatients with schizophrenia. Schizophr Res 2000; 41: 373-81.
23. Ziedonis DM, Kosten TR, Glazer WM, Frances RJ. Nicotine dependence and schizophrenia. Hosp Community Psychiatry 1994; 45: 204-6.
24. de Leon J, Diaz FJ. Worldwide studies demonstrate that there is an association between schizophrenia and tobacco smoking behaviors [enviado para publicar] 2004.
25. Woodward, M. Epidemiology, study design and data analysis. Boca Raton, Florida: Chapman & Hall; 1999.
26. Wilcox RR. Fundamentals of modern statistical methods. Nueva York: Springer-Verlag; 2001.
27. El-Guebaly N, Hodgins DC. Schizophrenia and substance abuse: prevalence issues. Can J Psychiatry 1992; 37: 704-10.
28. de Leon J, Becoña E, Gurpegui M, Gonzalez-Pinto A, Diaz FJ. The association between high nicotine dependence and severe mental illness may be consistent across countries. J Clin Psychiatry 2002; 63: 812-16.
29. Kelly C, McCreadie RG. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiatry 1999; 156: 1751-7.
30. Liao DL, Yang JY, Lee SM, Chen H, Tsai SJ. Smoking in chronic schizophrenic inpatients in Taiwan. Neuropsychobiology 2002; 45: 172-5.
31. Beratis S, Katrivanou A, Gourzis P. Factors affecting smoking in schizophrenia. Compr Psychiatry 2001; 42: 393-402.
32. McEvoy JP, Brown S. Smoking in first-episode patients with schizophrenia [letter]. Am J Psychiatry 1999; 156: 1120-1.
33. Fiore MC, Newcombe P, Mc Bride P. Natural history and epidemiology of tobacco use and addiction. Nicotine Adicction: Principles and Management. Nueva York: Oxford University Press; 1993. p. 89-104.
34. de Leon J. Smoking and vulnerability for schizophrenia. Schizophr Bull 1996; 22: 405-9.
35. Zammit S, Allebeck P, Dalman C. Investigating the association between cigarette smoking and schizophrenia in a cohort study. Am J Psychiatry 2003; 160: 2216-21.
36. Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC. Smoking and major depression: a causal analysis. Arch Gen Psychiatry 1993; 50: 36-43.
37. Adler LE, Olincy A, Waldo M, Harris JG, Griffith J, Stevens K, et al. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 1998; 24: 189-202.
38. Olincy A, Young DA, Freedman R. Increased levels of nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol Psychiatry 1997; 42: 1-5.
39. Leonard S, Gault J, Hopkins J, Logel J, Vianzon R, Short M, et al. Association of promoter variants in the α7 nicotine acetylcholine receptor gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry 2002; 59: 1085-96.
40. Drew AE, Derbez AE, Werling LL. Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex. Synapse 2000; 38: 10-6.
41. Caskey NH, Jarvik ME, Wirshing WC, Madsen DC, Iwamoto-Schaap PN, Eisenberger NI, et al. Modulating tobacco smoking rates by dopaminergic stimulation and blockade. Nicotine Tob Res 2002; 4: 259-66.
42. Goodman LS, Gilman A, Rall T, Nies A, Taylor P. Las bases farmacológicas de la terapéutica, ed 8. México: Editorial Panamericana; 1991. pp. 188-90.
43. Collins AC, Marks MG. Differential effect of chronic nicotine treatment on nicotinic receptor numbers in various brain regions of mice. J Subst Abuse 1989; 1: 273-86.
44. Rang HP, Dale MM. Farmacología. Barcelona: Churchill - Livingstone; 1992. p. 949-59.
45. Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenia patients. Am J Psychiatry 1993; 150: 1856-61.
46. Holder RJ, Mooney PA, Newman JC. Schizophrenia: an extended etiological explanation. Med Hypotheses 1994; 42: 115-23.
47. Holden RJ. Schizophrenia, smoking and smog. Holist Nurs Pract 1995; 9: 74-82.
48. Stimmel GL, Falloon I. Chlorpromazine plasma levels, adverse effects, and tobacco smoking - case report. J Clin Psychiatry 1983; 44: 420-2.
49. Lavin M, Siris S, Mason S. What is the clinical importance of cigarette smoking in schizophrenia? Am J Addict 1996; 5: 189-208.
50. Flórez J. Farmacología humana, ed 2. Barcelona: Masson-Salvat; 1994. p. 506-7.
51. Salokangas R, Saarijarvi S, Taiminen T, Lehto H, Niemi H, Ahola V, et al. Effect of smoking on neuroleptics in schizophrenia. Schizophr Res 1997; 23: 55-60.
52. McCarthy RH. Seizures following smoking cessation in a clozapine responder. Pharmacopsychiatry 1994; 27: 210-1.
53. McEvoy J, Freudenreich O, McGee M, VanderZwaag C, Levin E, Rose J. Clozapine decreases smoking in patients with chronic schizophrenia. Biol Psychiatry 1995; 37: 550-2.
54. Gurpegui M, Aguilar MC, Martinez-Ortega JM, Diaz FJ, de Leon J. Caffeine intake in outpatients with schizophrenia [en prensa]. Schizophr Bull 2004.
55. de Leon J: Glucuronidation enzymes, genes and psychiatry. Int J Neuropsychopharmacol 2003; 6: 57-72.
56. de Leon J. Psychopharmacology: atypical antipsychotic dosing: the effect of smoking (and caffeine) [enviado para publicar] 2004.
57. Gurpegui M, Aguilar MC, de León J. Smoking in schizophrenia: prevalence and associated features [abstract]. Eur Psychiatry 2000; 15 Suppl 2: 306s.
58. Diaz FJ, de Leon J. Excessive antipsychotic dosing in two state hospitals. J Clin Psychiatry 2002; 63: 998-1003.
59. Oyewumi LK. Smoking cessation and clozapine side effects. Can J Psychiatry 1998; 43: 748.
60. Skogh E, Bengtsson F, Nordin C. Could discontinuing smoking be hazardous for patients administered clozapine medication? A case report. Ther Drug Monit 1999; 21: 580-2.
61. Zullino DF, Delessert D, Eap CB, Preisig M, Baumann P. Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine. Int Clin Psychopharmacol. 2002; 17: 141-3.
62. Botts S, Littrell R, de Leon J. High olanzapine dosing in a state hospital [en prensa]. J Clin Psychiatry 2004.
63. McEvoy JP, Freudenreich O, Levin E, Rose JE. Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology 1995; 119: 124-6.
64. George TP, Ziedonis DM, Feingold A, Pepper WT, Satterburg CA, Winkel J, et al. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry 2000; 157: 1835-42.
65. George TP, Sernyak MJ, Ziedonis DM, Woods SW. Effects of clozapine on smoking in chronic schizophrenic out-patients. J Clin Psychiatry 1995; 56: 344-46.
66. de Leon J, Diaz FJ, Josiassen RC, Cooper TB, Simpson GM. Does clozapine decrease smoking? [Enviado para publicar] 2004.
67. 3H-dopamine release by nicotine in rats nucleus accumbens. J Neurochemi 1989; 49: 1449-54.
68. Nordberg A, Romanelli L, Sundwall A, Bianchi C, Beani L. Effect of acute and subchronic nicotine treatment on cortical acetylcholine release on nicotinic receptors in rats and guinea pigs. Br J Pharmacol 1989; 98: 71-8.
69. Svensson TH, Grenhoff J, Engberg G. Effect of nicotine on dynamic function of brain catecholamine neurons. Ciba Foundation Symposium 1990; 152: 169-80.
70. Hartman N, Leon GB, Glynn SM, Wilkins JN, Jarvik ME. Transdermal nicotine and smoking behavior in psychiatric patients. Am J Psychiatry 1991; 148: 374-5.
71. Lohr JB, Flynn K. Smoking and schizophrenia. Schizophr Res 1992; 8: 93-102.
72. Breslau N, Fenn N. Early smoking initiation and nicotine dependence in a cohort of young adults. Drug Alcohol Depend 1993; 33: 129-37.
73. Nisell M, Nomikos GG, Svensson TH. Nicotine dependence, midbrain dopamine systems and psychiatric disorders. Pharmacol Toxicol 1995; 76: 157-62.
74. Patkar A, Gopalakrishan R, Lundy A, Leone FT, Certa KM, Weinstein SP. Relationship between tobacco smoking and positive and negative symptoms of schizophrenia. J Nerv Ment Dis 2002; 190: 604-10.
75. Vinarova E, Vinar O, Kalvach Z. Smokers need higher doses of neuroleptic drugs. Biol Psychiatry 1984; 19: 1265-68.
76. Stasser K, Moeller-Saxone K, Meadows G, Hocking B, Stanton J, Kee P. Smoking cessation in schizophrenia. Aust Fam Physician 2002; 31: 21-4.
77. Aguilar MC, Gurpegui M, Diaz FJ, de Leon J. Nicotine dependence and symptoms in schizophrenia: a naturalistic study of complex interactions [enviado para publicar]. 2004.
78. Hall RG, Duhamel M, McClanhan R, Miles G, Nason C, Rosen S, et al. Level of functioning, severity of illness and smoking statu's among chronic psychiatric patients. J Nerv Ment Dis 1995; 183: 468-71.
79. El-Guebaly N, Cathcart J, Currie S, Brown D and Gloster S. Smoking cessation approaches for persons with mental illness or addictive disorders. Psychiatr Serv 2002; 53: 1166-70.
80. Addington J. Group treatment for smoking cessation among persons with schizophrenia. Psychiatr Serv 1998; 49: 925-30.
81. Evins AE, Mays VK, Rigotti NA, Tisdale T, Cather C and Goff DC. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine Tob Res 2001; 3: 397-403.
82. Weiner E, Ball MP, Summerfelt A, Gold J, Buchanan R. Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. Am J Psychiatry 2001; 158: 635-7
83. Roll JM, Higgins ST, Steingard S and McGinley M. Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: a feasibility study. Exp Clin Psychopharmacol 1998; 6: 157-61.
84. McChargue DE, Gulliver SB, Hitsman B. Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment. Addiction 2002, 97, 785-93.